Long-term safety and efficacy of preladenant in subjects with fluctuating Parkinson's disease.
Identifieur interne : 000929 ( Main/Exploration ); précédent : 000928; suivant : 000930Long-term safety and efficacy of preladenant in subjects with fluctuating Parkinson's disease.
Auteurs : Stewart A. Factor [États-Unis] ; Kenneth Wolski ; Daniel M. Togasaki ; Susan Huyck ; Marc Cantillon ; T W Ho ; Robert A. Hauser ; Emmanuelle PourcherSource :
- Movement disorders : official journal of the Movement Disorder Society [ 1531-8257 ] ; 2013.
English descriptors
- KwdEn :
- Aged, Antiparkinson Agents (therapeutic use), Dose-Response Relationship, Drug, Double-Blind Method, Humans, Longitudinal Studies, Middle Aged, Parkinson Disease (drug therapy), Parkinson Disease (physiopathology), Pyrimidines (therapeutic use), Severity of Illness Index, Triazoles (therapeutic use).
- MESH :
- chemical , therapeutic use : Antiparkinson Agents, Pyrimidines, Triazoles.
- drug therapy : Parkinson Disease.
- physiopathology : Parkinson Disease.
- Aged, Dose-Response Relationship, Drug, Double-Blind Method, Humans, Longitudinal Studies, Middle Aged, Severity of Illness Index.
Abstract
Preladenant is a selective adenosine A₂A receptor antagonist under investigation for Parkinson's disease treatment.
DOI: 10.1002/mds.25395
PubMed: 23589371
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 000940
- to stream PubMed, to step Curation: 000940
- to stream PubMed, to step Checkpoint: 000943
- to stream Ncbi, to step Merge: 003B41
- to stream Ncbi, to step Curation: 003B41
- to stream Ncbi, to step Checkpoint: 003B41
- to stream Main, to step Merge: 000929
- to stream Main, to step Curation: 000929
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Long-term safety and efficacy of preladenant in subjects with fluctuating Parkinson's disease.</title><author><name sortKey="Factor, Stewart A" sort="Factor, Stewart A" uniqKey="Factor S" first="Stewart A" last="Factor">Stewart A. Factor</name><affiliation wicri:level="1"><nlm:affiliation>Emory University School of Medicine, Department of Neurology, Atlanta, Georgia 30329, USA. sfactor@emory.edu</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Emory University School of Medicine, Department of Neurology, Atlanta, Georgia 30329</wicri:regionArea><wicri:noRegion>Georgia 30329</wicri:noRegion></affiliation></author><author><name sortKey="Wolski, Kenneth" sort="Wolski, Kenneth" uniqKey="Wolski K" first="Kenneth" last="Wolski">Kenneth Wolski</name></author><author><name sortKey="Togasaki, Daniel M" sort="Togasaki, Daniel M" uniqKey="Togasaki D" first="Daniel M" last="Togasaki">Daniel M. Togasaki</name></author><author><name sortKey="Huyck, Susan" sort="Huyck, Susan" uniqKey="Huyck S" first="Susan" last="Huyck">Susan Huyck</name></author><author><name sortKey="Cantillon, Marc" sort="Cantillon, Marc" uniqKey="Cantillon M" first="Marc" last="Cantillon">Marc Cantillon</name></author><author><name sortKey="Ho, T W" sort="Ho, T W" uniqKey="Ho T" first="T W" last="Ho">T W Ho</name></author><author><name sortKey="Hauser, Robert A" sort="Hauser, Robert A" uniqKey="Hauser R" first="Robert A" last="Hauser">Robert A. Hauser</name></author><author><name sortKey="Pourcher, Emmanuelle" sort="Pourcher, Emmanuelle" uniqKey="Pourcher E" first="Emmanuelle" last="Pourcher">Emmanuelle Pourcher</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2013">2013</date><idno type="doi">10.1002/mds.25395</idno><idno type="RBID">pubmed:23589371</idno><idno type="pmid">23589371</idno><idno type="wicri:Area/PubMed/Corpus">000940</idno><idno type="wicri:Area/PubMed/Curation">000940</idno><idno type="wicri:Area/PubMed/Checkpoint">000943</idno><idno type="wicri:Area/Ncbi/Merge">003B41</idno><idno type="wicri:Area/Ncbi/Curation">003B41</idno><idno type="wicri:Area/Ncbi/Checkpoint">003B41</idno><idno type="wicri:Area/Main/Merge">000929</idno><idno type="wicri:Area/Main/Curation">000929</idno><idno type="wicri:Area/Main/Exploration">000929</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Long-term safety and efficacy of preladenant in subjects with fluctuating Parkinson's disease.</title><author><name sortKey="Factor, Stewart A" sort="Factor, Stewart A" uniqKey="Factor S" first="Stewart A" last="Factor">Stewart A. Factor</name><affiliation wicri:level="1"><nlm:affiliation>Emory University School of Medicine, Department of Neurology, Atlanta, Georgia 30329, USA. sfactor@emory.edu</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Emory University School of Medicine, Department of Neurology, Atlanta, Georgia 30329</wicri:regionArea><wicri:noRegion>Georgia 30329</wicri:noRegion></affiliation></author><author><name sortKey="Wolski, Kenneth" sort="Wolski, Kenneth" uniqKey="Wolski K" first="Kenneth" last="Wolski">Kenneth Wolski</name></author><author><name sortKey="Togasaki, Daniel M" sort="Togasaki, Daniel M" uniqKey="Togasaki D" first="Daniel M" last="Togasaki">Daniel M. Togasaki</name></author><author><name sortKey="Huyck, Susan" sort="Huyck, Susan" uniqKey="Huyck S" first="Susan" last="Huyck">Susan Huyck</name></author><author><name sortKey="Cantillon, Marc" sort="Cantillon, Marc" uniqKey="Cantillon M" first="Marc" last="Cantillon">Marc Cantillon</name></author><author><name sortKey="Ho, T W" sort="Ho, T W" uniqKey="Ho T" first="T W" last="Ho">T W Ho</name></author><author><name sortKey="Hauser, Robert A" sort="Hauser, Robert A" uniqKey="Hauser R" first="Robert A" last="Hauser">Robert A. Hauser</name></author><author><name sortKey="Pourcher, Emmanuelle" sort="Pourcher, Emmanuelle" uniqKey="Pourcher E" first="Emmanuelle" last="Pourcher">Emmanuelle Pourcher</name></author></analytic><series><title level="j">Movement disorders : official journal of the Movement Disorder Society</title><idno type="eISSN">1531-8257</idno><imprint><date when="2013" type="published">2013</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Aged</term><term>Antiparkinson Agents (therapeutic use)</term><term>Dose-Response Relationship, Drug</term><term>Double-Blind Method</term><term>Humans</term><term>Longitudinal Studies</term><term>Middle Aged</term><term>Parkinson Disease (drug therapy)</term><term>Parkinson Disease (physiopathology)</term><term>Pyrimidines (therapeutic use)</term><term>Severity of Illness Index</term><term>Triazoles (therapeutic use)</term></keywords><keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Antiparkinson Agents</term><term>Pyrimidines</term><term>Triazoles</term></keywords><keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Parkinson Disease</term></keywords><keywords scheme="MESH" qualifier="physiopathology" xml:lang="en"><term>Parkinson Disease</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Aged</term><term>Dose-Response Relationship, Drug</term><term>Double-Blind Method</term><term>Humans</term><term>Longitudinal Studies</term><term>Middle Aged</term><term>Severity of Illness Index</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Preladenant is a selective adenosine A₂A receptor antagonist under investigation for Parkinson's disease treatment.</div></front></TEI><affiliations><list><country><li>États-Unis</li></country></list><tree><noCountry><name sortKey="Cantillon, Marc" sort="Cantillon, Marc" uniqKey="Cantillon M" first="Marc" last="Cantillon">Marc Cantillon</name><name sortKey="Hauser, Robert A" sort="Hauser, Robert A" uniqKey="Hauser R" first="Robert A" last="Hauser">Robert A. Hauser</name><name sortKey="Ho, T W" sort="Ho, T W" uniqKey="Ho T" first="T W" last="Ho">T W Ho</name><name sortKey="Huyck, Susan" sort="Huyck, Susan" uniqKey="Huyck S" first="Susan" last="Huyck">Susan Huyck</name><name sortKey="Pourcher, Emmanuelle" sort="Pourcher, Emmanuelle" uniqKey="Pourcher E" first="Emmanuelle" last="Pourcher">Emmanuelle Pourcher</name><name sortKey="Togasaki, Daniel M" sort="Togasaki, Daniel M" uniqKey="Togasaki D" first="Daniel M" last="Togasaki">Daniel M. Togasaki</name><name sortKey="Wolski, Kenneth" sort="Wolski, Kenneth" uniqKey="Wolski K" first="Kenneth" last="Wolski">Kenneth Wolski</name></noCountry><country name="États-Unis"><noRegion><name sortKey="Factor, Stewart A" sort="Factor, Stewart A" uniqKey="Factor S" first="Stewart A" last="Factor">Stewart A. Factor</name></noRegion></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000929 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000929 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Santé
|area= MovDisordV3
|flux= Main
|étape= Exploration
|type= RBID
|clé= pubmed:23589371
|texte= Long-term safety and efficacy of preladenant in subjects with fluctuating Parkinson's disease.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:23589371" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a MovDisordV3
| This area was generated with Dilib version V0.6.23. |  |